Global Hybrid Brain–Computer Interface (hBCI) Market Growth 2025-2031
Description
The global Hybrid Brain–Computer Interface (hBCI) market size is predicted to grow from US$ 474 million in 2025 to US$ 649 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
United States market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hybrid Brain–Computer Interface (hBCI) players cover Neuralink, NeuroSky, NeuroPace, EMOTIV, Blackrock Neurotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Hybrid Brain–Computer Interface (hBCI) Industry Forecast” looks at past sales and reviews total world Hybrid Brain–Computer Interface (hBCI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Hybrid Brain–Computer Interface (hBCI) sales for 2025 through 2031. With Hybrid Brain–Computer Interface (hBCI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hybrid Brain–Computer Interface (hBCI) industry.
This Insight Report provides a comprehensive analysis of the global Hybrid Brain–Computer Interface (hBCI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hybrid Brain–Computer Interface (hBCI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hybrid Brain–Computer Interface (hBCI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hybrid Brain–Computer Interface (hBCI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hybrid Brain–Computer Interface (hBCI).
This report presents a comprehensive overview, market shares, and growth opportunities of Hybrid Brain–Computer Interface (hBCI) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Invasive
Non-invasive
Segmentation by Application:
Healthcare
Entertainment and Education
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Neuralink
NeuroSky
NeuroPace
EMOTIV
Blackrock Neurotech
Compumedics
Advanced Brain Monitoring
G.TEC
Neuroelectrics
Brain Products
ANT Neuro
BrainCo
Neuracle
Flexolink
NeuralFlex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hybrid Brain–Computer Interface (hBCI) market?
What factors are driving Hybrid Brain–Computer Interface (hBCI) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hybrid Brain–Computer Interface (hBCI) market opportunities vary by end market size?
How does Hybrid Brain–Computer Interface (hBCI) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
United States market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hybrid Brain–Computer Interface (hBCI) players cover Neuralink, NeuroSky, NeuroPace, EMOTIV, Blackrock Neurotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Hybrid Brain–Computer Interface (hBCI) Industry Forecast” looks at past sales and reviews total world Hybrid Brain–Computer Interface (hBCI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Hybrid Brain–Computer Interface (hBCI) sales for 2025 through 2031. With Hybrid Brain–Computer Interface (hBCI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hybrid Brain–Computer Interface (hBCI) industry.
This Insight Report provides a comprehensive analysis of the global Hybrid Brain–Computer Interface (hBCI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hybrid Brain–Computer Interface (hBCI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hybrid Brain–Computer Interface (hBCI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hybrid Brain–Computer Interface (hBCI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hybrid Brain–Computer Interface (hBCI).
This report presents a comprehensive overview, market shares, and growth opportunities of Hybrid Brain–Computer Interface (hBCI) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Invasive
Non-invasive
Segmentation by Application:
Healthcare
Entertainment and Education
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Neuralink
NeuroSky
NeuroPace
EMOTIV
Blackrock Neurotech
Compumedics
Advanced Brain Monitoring
G.TEC
Neuroelectrics
Brain Products
ANT Neuro
BrainCo
Neuracle
Flexolink
NeuralFlex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hybrid Brain–Computer Interface (hBCI) market?
What factors are driving Hybrid Brain–Computer Interface (hBCI) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hybrid Brain–Computer Interface (hBCI) market opportunities vary by end market size?
How does Hybrid Brain–Computer Interface (hBCI) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
123 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Hybrid Brain–Computer Interface (hBCI) by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Hybrid Brain–Computer Interface (hBCI) by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
